Holocene Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-55,432
Closed -$18.1M 883
2024
Q1
$18.1M Buy
+55,432
New +$13.6M 0.07% 221
2022
Q3
Sell
-218,781
Closed -$41.8M 984
2022
Q2
$41.8M Buy
218,781
+134,243
+159% +$23.7M 0.25% 122
2022
Q1
$17.5M Buy
+84,538
New +$13.9M 0.09% 195
2021
Q2
Sell
-258,419
Closed -$33.7M 960
2021
Q1
$33.7M Sell
258,419
-249,537
-49% -$29.9M 0.21% 134
2020
Q4
$52.7M Buy
507,956
+418,660
+469% +$36.3M 0.33% 110
2020
Q3
$6.77M Buy
+89,296
New +$5.06M 0.05% 245

Other funds holding SWAV

Holocene Advisors's SWAV Position: Q2 2024 in Review

Holocene Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 55,432 shares — an estimated $18.1M sold.

Holocene Advisors first reported a position in SWAV in Q3 2020 and held it in 6 quarters. The position peaked at $52.7M in Q4 2020. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Holocene Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Holocene Advisors sold 55,432 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $18.1M.
  • Holocene Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Holocene Advisors's Shockwave Medical, Inc. Common Stock position peaked at $52.7M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Holocene Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.